<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">34991434</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>02</Month>
        <Day>14</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>02</Month>
        <Day>14</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2222-1751</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>11</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Emerging microbes &amp; infections</Title>
          <ISOAbbreviation>Emerg Microbes Infect</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Genomic epidemiology and characterisation of penicillin-sensitive <i>Staphylococcus aureus</i> isolates from invasive bloodstream infections in China: an increasing prevalence and higher diversity in genetic typing be revealed.</ArticleTitle>
        <Pagination>
          <StartPage>326</StartPage>
          <EndPage>336</EndPage>
          <MedlinePgn>326-336</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/22221751.2022.2027218</ELocationID>
        <Abstract>
          <AbstractText>Many countries have reported increasing rates of penicillin-susceptible methicillin-sensitive <i>Staphylococcus aureus</i> (MSSA-PEN<sup>S</sup>). To date, there is relatively little known about the current situation and molecular characteristics of MSSA-PEN<sup>S</sup> in China. In this study, we carried out a laboratory-based multi-region retrospective study to investigate the genomic epidemiology and characterisation of MSSA-PEN<sup>S</sup> isolated from invasive bloodstream infections (BSIs) across 17 provinces. The prevalence of MSSA-PEN<sup>S</sup> isolates increased significantly over the 6-year period, with the proportion increasing from 3.51% in 2014-8.80% in 2019, an average relative increase of 22.14% per year (95% confidence interval 9.67%-34.61%, P for trend &lt;0.001), suggesting that China is experiencing a resurgence of MSSA-PEN<sup>S</sup>. Phylogenetic analysis showed a higher strain diversity occurred; the most frequent clonal complexes (CCs) identified were CC188 (17.14%), CC398 (15.71%) and CC5 (15.71%). Over half of MSSA-PEN<sup>S</sup> strains were pan-susceptible, with erythromycin the most frequent resistance observed. Moreover, 25 isolates were identified as immune evasion cluster negative, including CC15, CC188 and CC1, and 6 strains encoded the Panton-Valentine leucocidin gene. Importantly, virulence assays showed that MSSA-PEN<sup>S</sup> exhibited a level of virulence comparable to that of penicillin-resistant MSSA (MSSA-PEN<sup>R</sup>), indicating that more-sensitive strains should not be mistaken for lacking aggressiveness in <i>vivo</i>. Furthermore, 11 of these isolates were confirmed as <i>blaZ</i> positive but phenotype sensitive, with different amino acid changes in <i>blaZ</i>. Our data support the recommendation to clinicians regarding the usage of penicillin in invasive BSIs caused by MSSA-PEN<sup>S</sup>, which might create a novel opportunity for better antimicrobial stewardship in the future.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Jin</LastName>
            <ForeName>Ye</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhou</LastName>
            <ForeName>Wangxiao</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhan</LastName>
            <ForeName>Qing</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>Infection Control Department, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Yunbo</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Luo</LastName>
            <ForeName>Qixia</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shen</LastName>
            <ForeName>Ping</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xiao</LastName>
            <ForeName>Yonghong</ForeName>
            <Initials>Y</Initials>
            <Identifier Source="ORCID">0000-0003-4845-5904</Identifier>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Jinan Microecological Biomedicine Shandong Laboratory, Jinan, People's Republic of China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Emerg Microbes Infect</MedlineTA>
        <NlmUniqueID>101594885</NlmUniqueID>
        <ISSNLinking>2222-1751</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D010406">Penicillins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D037521">Virulence Factors</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D023281" MajorTopicYN="N">Genomics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055624" MajorTopicYN="Y">Methicillin-Resistant Staphylococcus aureus</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008826" MajorTopicYN="N">Microbial Sensitivity Tests</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010406" MajorTopicYN="N">Penicillins</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010802" MajorTopicYN="N">Phylogeny</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013203" MajorTopicYN="Y">Staphylococcal Infections</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013211" MajorTopicYN="N">Staphylococcus aureus</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D037521" MajorTopicYN="N">Virulence Factors</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Penicillin sensitivity</Keyword>
        <Keyword MajorTopicYN="N">blaZ</Keyword>
        <Keyword MajorTopicYN="N">bloodstream infections</Keyword>
        <Keyword MajorTopicYN="N">genomic epidemiology</Keyword>
        <Keyword MajorTopicYN="N">methicillin-susceptible Staphylococcus aureus</Keyword>
      </KeywordList>
      <CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>7</Day>
          <Hour>5</Hour>
          <Minute>37</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34991434</ArticleId>
        <ArticleId IdType="pmc">PMC8786255</ArticleId>
        <ArticleId IdType="doi">10.1080/22221751.2022.2027218</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Cosgrove SE, Sakoulas G, Perencevich EN, et al. . 
Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis. 2003;36:53–59. doi:10.1086/345476.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/345476</ArticleId>
            <ArticleId IdType="pubmed">12491202</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Naber CK.
Staphylococcus aureus bacteremia: epidemiology, pathophysiology, and management strategies. Clin Infect Dis. 2009;48(Suppl 4):S231–S237. doi:10.1086/598189.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/598189</ArticleId>
            <ArticleId IdType="pubmed">19374578</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van Hal SJ, Jensen SO, Vaska VL, et al. . 
Predictors of mortality in Staphylococcus aureus bacteremia. Clin Microbiol Rev. 2012;25:362–386. doi:10.1128/CMR.05022-11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/CMR.05022-11</ArticleId>
            <ArticleId IdType="pmc">PMC3346297</ArticleId>
            <ArticleId IdType="pubmed">22491776</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bai AD, Showler A, Burry L, et al. . 
Impact of Infectious Disease consultation on quality of care, mortality, and length of stay in Staphylococcus aureus bacteremia: Results from a large multicenter cohort study. Clin Infect Dis. 2015;60:1451–1461. DOI:10.1093/cid/civ120.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cid/civ120</ArticleId>
            <ArticleId IdType="pubmed">25701854</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stryjewski ME, Szczech LA, Benjamin
DK, Jr., et al. . 
Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia. Clin Infect Dis
2007. 44. 190-196. doi:10.1086/510386</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/510386</ArticleId>
            <ArticleId IdType="pubmed">17173215</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim SH, Kim KH, Kim HB, et al. . 
Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia. Antimicrob Agents Chemother. 2008;52:192–197. DOI:10.1128/aac.00700-07.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/aac.00700-07</ArticleId>
            <ArticleId IdType="pmc">PMC2223910</ArticleId>
            <ArticleId IdType="pubmed">17984229</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>González C, Rubio M, Romero-Vivas J, et al. . 
Bacteremic pneumonia due to Staphylococcus aureus: A comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms. Clin Infect Dis. 1999;29:1171–1177. doi:10.1086/313440.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/313440</ArticleId>
            <ArticleId IdType="pubmed">10524959</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chambers HF.
The changing epidemiology of Staphylococcus aureus?
Emerg Infect Dis. 2001;7:178–182. DOI:10.3201/eid0702.010204.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid0702.010204</ArticleId>
            <ArticleId IdType="pmc">PMC2631711</ArticleId>
            <ArticleId IdType="pubmed">11294701</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lowy FD.
Staphylococcus aureus infections. N Engl J Med. 1998;339:520–532. doi:10.1056/NEJM199808203390806.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJM199808203390806</ArticleId>
            <ArticleId IdType="pubmed">9709046</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koeck M, Como-Sabetti K, Boxrud D, et al. . 
Burdens of invasive methicillin-susceptible and methicillin-resistant Staphylococcus aureus disease, minnesota, USA. Emerg Infect Dis. 2019;25:171–174. DOI:10.3201/eid2501.181146.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid2501.181146</ArticleId>
            <ArticleId IdType="pmc">PMC6302582</ArticleId>
            <ArticleId IdType="pubmed">30561319</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chabot MR, Stefan MS, Friderici J, et al. . 
Reappearance and treatment of penicillin-susceptible Staphylococcus aureus in a tertiary medical centre. J Antimicrob Chemother. 2015;70:3353–3356. DOI:10.1093/jac/dkv270.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jac/dkv270</ArticleId>
            <ArticleId IdType="pubmed">26342027</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Richter SS, Doern GV, Heilmann KP, et al. . 
Detection and prevalence of penicillin-susceptible Staphylococcus aureus in the United States in 2013. J Clin Microbiol. 2016;54:812–814. DOI:10.1128/jcm.03109-15.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/jcm.03109-15</ArticleId>
            <ArticleId IdType="pmc">PMC4767943</ArticleId>
            <ArticleId IdType="pubmed">26763960</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Henderson A, Harris P, Hartel G, et al. . 
Benzylpenicillin versus flucloxacillin for penicillin-susceptible Staphylococcus aureus bloodstream infections from a large retrospective cohort study. Int J Antimicrob Agents. 2019;54:491–495. DOI:10.1016/j.ijantimicag.2019.05.020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijantimicag.2019.05.020</ArticleId>
            <ArticleId IdType="pubmed">31181352</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nissen JL, Skov R, Knudsen JD, et al. . 
Effectiveness of penicillin, dicloxacillin and cefuroxime for penicillin-susceptible Staphylococcus aureus bacteraemia: a retrospective, propensity-score-adjusted case-control and cohort analysis. J Antimicrob Chemother. 2013;68:1894–1900. DOI:10.1093/jac/dkt108.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jac/dkt108</ArticleId>
            <ArticleId IdType="pubmed">23599360</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Butler-Laporte G, Lee TC, Cheng MP.. 
Increasing rates of penicillin sensitivity in Staphylococcus aureus. Antimicrob Agents Chemother. 2018;62; doi:10.1128/AAC.00680-18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.00680-18</ArticleId>
            <ArticleId IdType="pmc">PMC6021674</ArticleId>
            <ArticleId IdType="pubmed">29686148</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen S, Zhou Y, Chen Y, et al. . . fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics. 2018;34:i884–i890. DOI:10.1093/bioinformatics/bty560.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/bioinformatics/bty560</ArticleId>
            <ArticleId IdType="pmc">PMC6129281</ArticleId>
            <ArticleId IdType="pubmed">30423086</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Prjibelski A, Antipov D, Meleshko D, et al. . 
Using SPAdes De novo assembler. Curr Protoc Bioinformatics. 2020;70:e102), DOI:10.1002/cpbi.102.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/cpbi.102</ArticleId>
            <ArticleId IdType="pubmed">32559359</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bortolaia V, Kaas RS, Ruppe E, et al. . 
Resfinder 4.0 for predictions of phenotypes from genotypes. J Antimicrob Chemother. 2020;75:3491–3500. DOI:10.1093/jac/dkaa345.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jac/dkaa345</ArticleId>
            <ArticleId IdType="pmc">PMC7662176</ArticleId>
            <ArticleId IdType="pubmed">32780112</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zankari E, Allesøe R, Joensen KG, et al. . 
Pointfinder: a novel web tool for WGS-based detection of antimicrobial resistance associated with chromosomal point mutations in bacterial pathogens. J Antimicrob Chemother. 2017;72:2764–2768. DOI:10.1093/jac/dkx217.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jac/dkx217</ArticleId>
            <ArticleId IdType="pmc">PMC5890747</ArticleId>
            <ArticleId IdType="pubmed">29091202</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carvajal LP, Rincon S, Echeverri AM, et al. . 
Novel insights into the classification of staphylococcal β-lactamases in Relation to the Cefazolin Inoculum effect. Antimicrob Agents Chemother. 2020;64; DOI:10.1128/aac.02511-19.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/aac.02511-19</ArticleId>
            <ArticleId IdType="pmc">PMC7179603</ArticleId>
            <ArticleId IdType="pubmed">32071048</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Page AJ, Cummins CA, Hunt M, et al. . 
Roary: rapid large-scale prokaryote pan genome analysis. Bioinformatics. 2015;31:3691–3693. DOI:10.1093/bioinformatics/btv421.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/bioinformatics/btv421</ArticleId>
            <ArticleId IdType="pmc">PMC4817141</ArticleId>
            <ArticleId IdType="pubmed">26198102</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stamatakis A.
RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics. 2014;30:1312–1313.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3998144</ArticleId>
            <ArticleId IdType="pubmed">24451623</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu G.
Using ggtree to visualize data on tree-like structures. Curr Protoc Bioinformatics. 2020;69:e96), DOI:10.1002/cpbi.96.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/cpbi.96</ArticleId>
            <ArticleId IdType="pubmed">32162851</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jin Y, Yu X, Chen Y, et al. . 
Characterization of highly virulent community-associated methicillin-resistant Staphylococcus aureus ST9-SCCmec XII causing bloodstream infection in China. Emerg Microbes Infect. 2020;9:2526–2535. doi:10.1080/22221751.2020.1848354.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/22221751.2020.1848354</ArticleId>
            <ArticleId IdType="pmc">PMC7717876</ArticleId>
            <ArticleId IdType="pubmed">33174510</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vandendriessche S, Kadlec K, Schwarz S, et al. . 
Methicillin-susceptible Staphylococcus aureus ST398-t571 harbouring the macrolide-lincosamide-streptogramin B resistance gene erm(T) in Belgian hospitals. J Antimicrob Chemother. 2011;66:2455–2459. DOI:10.1093/jac/dkr348.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jac/dkr348</ArticleId>
            <ArticleId IdType="pubmed">21868413</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tavares A, Faria NA, de Lencastre H, et al. . 
Population structure of methicillin-susceptible Staphylococcus aureus (MSSA) in Portugal over a 19-year period (1992-2011). Eur. J. Clin. Microbiol. Infect. Dis.
2014;33:423–432. DOI:10.1007/s10096-013-1972-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10096-013-1972-z</ArticleId>
            <ArticleId IdType="pubmed">24057140</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jin Y, Zhou W, Zhan Q, et al. . 
Genomic epidemiology and Characterization of methicillin-resistant Staphylococcus aureus from bloodstream infections in China. mSystems. 2021;6:e0083721, DOI:10.1128/mSystems.00837-21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/mSystems.00837-21</ArticleId>
            <ArticleId IdType="pmc">PMC8562482</ArticleId>
            <ArticleId IdType="pubmed">34726482</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen L, Chavda KD, Solanki M, et al. . 
Genetic variation among Panton-Valentine leukocidin-encoding bacteriophages in Staphylococcus aureus clonal complex 30 strains. J Clin Microbiol. 2013;51:914–919. DOI:10.1128/jcm.03015-12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/jcm.03015-12</ArticleId>
            <ArticleId IdType="pmc">PMC3592069</ArticleId>
            <ArticleId IdType="pubmed">23284024</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao C, Liu Y, Zhao M, et al. . 
Characterization of community acquired Staphylococcus aureus associated with skin and soft tissue infection in Beijing: high prevalence of PVL+ ST398. PloS one. 2012;7:e38577), DOI:10.1371/journal.pone.0038577.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0038577</ArticleId>
            <ArticleId IdType="pmc">PMC3368899</ArticleId>
            <ArticleId IdType="pubmed">22701673</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baines SL, Holt KE, Schultz MB, et al. . 
Convergent adaptation in the dominant global hospital clone ST239 of methicillin-resistant Staphylococcus aureus. mBio. 2015;6:e00080), DOI:10.1128/mBio.00080-15.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/mBio.00080-15</ArticleId>
            <ArticleId IdType="pmc">PMC4358018</ArticleId>
            <ArticleId IdType="pubmed">25736880</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harris SR, Feil EJ, Holden MT, et al. . 
Evolution of MRSA during hospital transmission and intercontinental spread. Science (New York, N.Y.). 2010;327:469–474. DOI:10.1126/science.1182395.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.1182395</ArticleId>
            <ArticleId IdType="pmc">PMC2821690</ArticleId>
            <ArticleId IdType="pubmed">20093474</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mama OM, Aspiroz C, Lozano C, et al. . 
Penicillin susceptibility among invasive MSSA infections: a multicentre study in 16 spanish hospitals. J Antimicrob Chemother. 2021;76:2519–2527. DOI:10.1093/jac/dkab208.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jac/dkab208</ArticleId>
            <ArticleId IdType="pubmed">34245259</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li X, Fang F, Zhao J, et al. . 
Molecular characteristics and virulence gene profiles of Staphylococcus aureus causing bloodstream infection. Braz J Infect Dis. 2018;22:487–494. DOI:10.1016/j.bjid.2018.12.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bjid.2018.12.001</ArticleId>
            <ArticleId IdType="pubmed">30594541</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ai X, Gao F, Yao S, et al. . 
Prevalence, characterization, and drug resistance of Staphylococcus aureus in feces from pediatric patients in guangzhou, China. Front Med (Lausanne)
2020. 7. 127. DOI:10.3389/fmed.2020.00127</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fmed.2020.00127</ArticleId>
            <ArticleId IdType="pmc">PMC7193981</ArticleId>
            <ArticleId IdType="pubmed">32391366</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dong Q, Liu Y, Li W, et al. . 
Phenotypic and molecular characteristics of community-associated Staphylococcus aureus infection in neonates. Infect Drug Resist. 2020;13:4589–4600. DOI:10.2147/idr.S284781.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/idr.S284781</ArticleId>
            <ArticleId IdType="pmc">PMC7765684</ArticleId>
            <ArticleId IdType="pubmed">33376365</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith TC, Wardyn SE.. 
Human infections with Staphylococcus aureus CC398. Curr Environ Health Rep. 2015;2:41–51. DOI:10.1007/s40572-014-0034-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s40572-014-0034-8</ArticleId>
            <ArticleId IdType="pubmed">26231241</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Resman F, Thegerström J, Månsson F, et al. . 
The prevalence, population structure and screening test specificity of penicillin-susceptible Staphylococcus aureus bacteremia isolates in malmö, Sweden. J Infect. 2016;73:129–135. DOI:10.1016/j.jinf.2016.05.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jinf.2016.05.011</ArticleId>
            <ArticleId IdType="pubmed">27265236</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Price LB, Stegger M, Hasman H, et al. . 
Staphylococcus aureus CC398: host adaptation and emergence of methicillin resistance in livestock. mBio. 2012;3; DOI:10.1128/mBio.00305-11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/mBio.00305-11</ArticleId>
            <ArticleId IdType="pmc">PMC3280451</ArticleId>
            <ArticleId IdType="pubmed">22354957</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Uhlemann AC, Porcella SF, Trivedi S, et al. . 
Identification of a highly transmissible animal-independent Staphylococcus aureus ST398 clone with distinct genomic and cell adhesion properties. mBio. 2012;3; DOI:10.1128/mBio.00027-12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/mBio.00027-12</ArticleId>
            <ArticleId IdType="pmc">PMC3302565</ArticleId>
            <ArticleId IdType="pubmed">22375071</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He L, Zheng HX, Wang Y, et al. . 
Detection and analysis of methicillin-resistant human-adapted sequence type 398 allows insight into community-associated methicillin-resistant Staphylococcus aureus evolution. Genome Med
2018. 10. 5. DOI:10.1186/s13073-018-0514-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13073-018-0514-9</ArticleId>
            <ArticleId IdType="pmc">PMC5789642</ArticleId>
            <ArticleId IdType="pubmed">29378646</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ba XL, Harrison EM, Lovering AL, et al. . 
Old drugs To treat resistant bugs: methicillin-resistant Staphylococcus aureus isolates with mecC Are susceptible to a combination of penicillin and clavulanic acid. Antimicrob Agents Chemother. 2015;59(12):7396–7404. DOI:10.1128/aac.01469-15.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/aac.01469-15</ArticleId>
            <ArticleId IdType="pmc">PMC4649192</ArticleId>
            <ArticleId IdType="pubmed">26392513</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miller WR, Seas C, Carvajal LP, et al. . 
The cefazolin Inoculum Effect Is associated With increased mortality in methicillin-susceptible Staphylococcus aureus bacteremia. Open Forum Infect Dis. 2018;5:ofy123, DOI:10.1093/ofid/ofy123.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/ofid/ofy123</ArticleId>
            <ArticleId IdType="pmc">PMC6007512</ArticleId>
            <ArticleId IdType="pubmed">29977970</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee S, Song KH, Jung SI, et al. . 
Comparative outcomes of cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective multicentre cohort study in korea. Clin Microbiol Infect. 2018;24:152–158. DOI:10.1016/j.cmi.2017.07.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmi.2017.07.001</ArticleId>
            <ArticleId IdType="pubmed">28694202</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
